Immunology

JUST IN: We’ve signed a definitive agreement to acquire Nimble Therapeutics to further strengthen our #immunology pipeline. This agreement represents an important growth opportunity and supports our ongoing commitment to developing novel medicines for people living with #autoimmune diseases. Learn more: https://bit.ly/3DdK2Pb [Video description: On-screen text reads, “Immunology News .”]

New findings from a global study showed that 52% of patients with #CrohnsDisease and 44% of patients with #UlcerativeColitis had suboptimal disease control. Hear two of our leaders detail how the unmet medical need in #IBD fuels our R&D efforts to raise the standard of care: https://bit.ly/3CNXQ2D [Video description: AbbVie leaders explain the IBD PODCAST study results and how our R&D teams are working to continue raising the standard of care for patients with immune-mediated diseases.]

Today on #WorldPsoriasisDay, we are reminded that psoriatic disease not only impacts the patient, but also their loved ones, including families, partners and caregivers. Through ongoing research and dedication to immune-mediated skin diseases, like psoriasis, we strive to meet patient needs and support the community globally. IFPA's report highlights the full impact of psoriasis: https://bit.ly/4hq1j7h [Video description: Vassilis Stakias, Global TA Lead, Dermatology, Global Medical Affairs, AbbVie, says, “Everyday, we prioritize the needs of the patients living with psoriatic disease, so they can feel free in their own skin. This World Psoriasis Day, we also support and recognize how psoriatic disease can impact those beyond the patient in solidarity with the dermatology community.”]

At least 60 million people live with psoriatic disease globally. This #WorldPsoriasisDay, we are raising awareness about how this immune-mediated skin disease can impact both the individual and their surrounding loved ones. As we aim to destigmatize #psoriasis and empower patients, we encourage those impacted to engage in meaningful conversations with their doctors to achieve their long-term goals. Learn more about the full impact of psoriasis: https://bit.ly/4e5RYhW [Video description: Animation of a woman, a family, families depicted above the Earth, two people in a room, a family cleaning a home, a family at the pool and a doctor and patient at a desk. On-screen text reads, “Psoriasis is a condition that affects more than just the skin. It impacts the lives of patients and their families worldwide. 90% of family members report that their quality of life is impacted by their relative’s psoriasis. People with psoriasis often avoid leisure activities, missing out on time with family. Family members of people with psoriasis often do more around the house to lighten the load. Learn more about the full impact of psoriasis."]

Inflammatory bowel disease (#IBD) is a complex condition that can have a profound impact on a person’s mental and physical well-being. To learn more about the importance of optimal disease management, explore our excerpt in the October edition of the European Federation of Crohn's and Ulcerative Colitis Associations magazine: https://bit.ly/4eLrFP5

NEWS: New post-hoc data of #atopicdermatitis stratified by the severity of disease in the head and neck region was presented today at the #EADVCongress. Learn more about how we’re striving to meet patient needs through new research and data in immune-mediated skin diseases: https://bit.ly/3zteu6r [Video description: On-screen text reads, “Immunology News.”]

Tune into this year’s #EADVCongress to see how we’re striving to meet patient needs through new research and data in immune-mediated skin diseases: https://bit.ly/47Gie0P [Video description: Animation of people, a person speaking at a podium, and Amsterdam on a map. On-screen text reads, “EADV 2024 Looking ahead. 33 accepted abstracts across 5 immune-mediated skin diseases, atopic dermatitis, psoriasis, psoriatic arthritis, vitiligo, hidradenitis suppurativa, 6 oral presentations, 3 symposia. See you there!”]

#Eczema is a chronic, inflammatory condition caused by several factors, including an overactive immune system. This disease can impact one’s life physically and emotionally, beyond dry skin and itch. This upcoming #AtopicEczemaDay, we’re committed to empowering those that live with eczema to have honest conversations with their dermatologist. Learn more: https://bit.ly/3znj7Pb [Image description: On-screen text reads: “Over 200 million people globally live with atopic eczema, making it one of the most prevalent immune-mediated skin diseases on the planet.” Followed by a quote from Yolanda Armendariz, Senior Director, Therapeutic Area Lead, Dermatology, Medical Affairs & HEOR, Global Therapeutics, AbbVie, “In collaboration with the dermatology community, we work every day for people living with atopic eczema so they can live confidently in their skin.”]

We’re striving to make a difference for people impacted by #IBD. Learn how we’re working to reimagine the standards of care through innovation and research: https://abbv.ie/cb1af7 #UlcerativeColitis #CrohnsDisease [Image description: Roopal Thakkar, M.D., EVP, R&D, Chief Scientific Officer, AbbVie, says, "We are committed to strengthening our diversified inflammatory bowel disease (IBD) portfolio, providing healthcare professionals with more options to treat their IBD patients."]